NCT06993116View on ClinicalTrials.gov

A Phase I Study of SHR-4712 in Patients With Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

June 9, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Advanced Solid Tumor
Interventions
DRUG

SHR-4712 Injection

SHR-4712 injection.

Trial Locations (2)

350014

RECRUITING

Fujian Cancer Hospital, Fuzhou

410013

RECRUITING

Hunan Cancer Hospital, Changsha

All Listed Sponsors
lead

Guangdong Hengrui Pharmaceutical Co., Ltd

INDUSTRY